Cancer vaccine designed from homologous ferritin-based fusion protein with enhanced DC-T cell crosstalk for durable adaptive immunity against tumors.

Bioact Mater · 2025 · PMC11764028 · PMID 39868073

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The protein expression levels of the three genes were subsequently analyzed using Western Blot, which showed a trend consistent with the qPCR data ( Fig. 3 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.